HemaSphere (Jun 2022)

P569: GILTERITINIB AND QUIZARTINIB IN RELAPSED/REFRACTORY (R/R) ACUTE MYELOBLASTIC LEUKEMIA (AML) WITH FLT3 MUTATIONS: A REAL-LIFE EFFECTIVENESS AND SAFETY STUDY

  • D. Quintela,
  • M. Morgades,
  • A. Serrano,
  • M. Cervera,
  • A. Balerdi,
  • M. Díaz-Beyá,
  • M. Arnan,
  • A. Garrido,
  • R. Coll,
  • M. Tormo,
  • J. López-Marin,
  • B. Merchan,
  • S. Garcia,
  • M. Casado,
  • A. Sampol,
  • J. Esteve,
  • D. Martínez-Cuadrón,
  • J. Sierra,
  • M. Á. Sanz,
  • J. M. Ribera,
  • P. Montesinos,
  • S. Vives

DOI
https://doi.org/10.1097/01.HS9.0000845164.12158.18
Journal volume & issue
Vol. 6
pp. 468 – 469

Abstract

Read online

No abstracts available.